We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock

Delisted

CDMO was delisted on the 4th of February, 2025.

101 hedge funds and large institutions have $91.9M invested in Avid Bioservices, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,675% more call options, than puts

Call options by funds: $142K | Put options by funds: $8K

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

36% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 22

6% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 16

0% more funds holding

Funds holding: 101101 (0)

20% less capital invested

Capital invested by funds: $114M → $91.9M (-$22.5M)

Holders
101
Holders Change
Holders Change %
0%
% of All Funds
2.25%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
17
Increased
30
Reduced
22
Closed
16
Calls
$142K
Puts
$8K
Net Calls
+$134K
Net Calls Change
+$320K

CDMO Hedge Fund Activity: Q4 2018 in Review

101 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q4 2018, worth a combined $91.9M — down 20% from $114M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new CDMO positions and 16 closed out — a net gain of 1 holder — while 30 added to existing stakes and 22 trimmed.

The largest buyer was Legato Capital Management, opening a new position worth an estimated $1.24M. The largest seller was Bandera Partners, cutting an estimated $2.34M.

  • 101 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q4 2018, unchanged from Q3 2018.
  • Funds reported $91.9M of Avid Bioservices, Inc. Common Stock stock for Q4 2018, down 20% quarter-over-quarter.
  • 17 funds opened new Avid Bioservices, Inc. Common Stock positions in Q4 2018 and 16 closed out, a net change of +1 holder.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q4 2018 was Legato Capital Management, an estimated $1.24M added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q4 2018 was Bandera Partners, an estimated $2.34M sold.

Based on aggregated 13F filings for Q4 2018.